Abstract
Epidermal growth factor receptor (EGFR) inhibitors, as a first-line drug treatment in the EGFR-sensitive mutation of advanced non-small-cell lung canc......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
